Home Recalls D-0094-2023
Class III · Low risk Terminated Initiated Dec 6, 2022 (4 years ago)
Lacosamide Oral Solution, USP, CV, 10mg/mL, packaged in 200 mL bottle, Rx Only…
Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.
Why it was recalled
Failed Excipient Specifications: out of specification result observed for p-Hydroxybenzoic Acid content
What was recalled
Lacosamide Oral Solution, USP, CV, 10mg/mL, packaged in 200 mL bottle, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Manufactured By: HETERO LABS LIMITED, Jeedimetla, Hyderabad - 500 055, India, NDC 31722-627-26
Recalling firm Camber Pharmaceuticals, Inc
NDC code 31722-627-26
Origin NJ, United States
Initiated by Voluntary: Firm initiated
FDA recall number D-0094-2023
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Class II · Moderate risk Ongoing Jun 4, 2026
Reason Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.
Class II · Moderate risk Ongoing May 28, 2025
Reason Defective Container: This recall is being initiated due to a leaking unit stored horizontally.
Class II · Moderate risk Ongoing Mar 13, 2025
Reason CGMP Deviations
Class II · Moderate risk Ongoing Mar 13, 2025
Reason CGMP Deviations
Class II · Moderate risk Ongoing Mar 13, 2025
Reason CGMP Deviations